News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Piotr Wysocki: How can we optimize the endocrine treatment of advanced HR+/HER2- breast cancer?
Photo taken from Piotr Wysocki/LinkedIn
Mar 23, 2024, 04:35

Piotr Wysocki: How can we optimize the endocrine treatment of advanced HR+/HER2- breast cancer?

Piotr Wysocki, Professor of Medicine, Head of Department of Oncology at Jagiellonian University Hospital, recently shared on LinkedIn:

“I want to share with you my personal view on the optimal utilisation of currently available treatments for advanced HR+/HER2- breast cancer. The review published online in JCO Oncology Practice summarizes the available data on the efficacy and safety of various therapeutic strategies in relationship to current reimbursement limitations in Poland and many other EU countries (lack of reimbursement of everolimus and unavailability of capivasertib). You can download the whole paper here.”

Piotr Wysocki: How can we optimize the endocrine treatment of advanced HR+/HER2- breast cancer?

Source: Piotr Wysocki/LinkedIn

Breast Cancer cancer Capivasertib endocrine treatment everolimus HR+/HER2- breast cancer JCO Oncology Practice OncoDaily Oncology Piotr Wysocki Poland review treatments for cancer
Special Coverage
Blog
Nov 21, 2024, 06:52
Sylvester’s third annual Art is Medicine exhibit's new theme is "The Bridge to Bahia"
Blog
Nov 21, 2024, 06:49
OncoInfluencers to Follow on Social Media: Dr. Melvin L.K. Chua
Blog
Nov 21, 2024, 06:44
Hedley Lewis: Gratitude to all The Cows who participated in the Virgin Active South Africa Ride Joburg
Insight
Nov 21, 2024, 06:29
Sami Mansfield: What if improving metabolic health could reduce cancer risks and improve outcomes?
Blog
Nov 21, 2024, 06:27
Julie Gralow: Comprehensive Genomic Profiling Improves Precision Therapy Use And Patient Survival
Insight
Nov 20, 2024, 20:44
Baris Turkbey: Excited to announce NCI Molecular Imaging members presenting their research at RSNA2024
Blog
Nov 20, 2024, 20:38
Franklin Iheanacho: Changing treatment patterns for hepatocellular carcinoma
Insight
Nov 20, 2024, 20:27
HIPEC improves overall survival in recurrent epithelial ovarian cancer
Blog
Nov 20, 2024, 19:12
Medicaid Cancer Foundation at 1Ummah Annual Convention
Insight
Nov 20, 2024, 19:12
Sahar Mansour: Advancing Breast Microcalcification Detection with AI
Blog
Nov 20, 2024, 19:12
Reflecting on Progress and Partnerships in Lung Cancer Care – Sarah Cannon Research Institute
Blog
Nov 20, 2024, 19:12
Virtual tumor board on the management of a patient with Metastatic Squamous NSCLC - IASLC